Navigation Links
Dr. Laura T. Lawrence, Board Certified Reproductive Endocrinologist, Joins Dallas-Fort Worth Fertility Associates
Date:8/5/2014

(PRWEB) August 05, 2014

For over 15 years, Dallas-Fort Worth Fertility Associates has offered compassionate care and medical expertise to area residents struggling to conceive. Drs. Samuel Chantilis, Karen Lee, Mika Thomas and Ravi Gada deliver leading-edge therapies that help infertile couples achieve their dreams of parenthood. As part of a continued commitment to their patients, Dallas-Fort Worth Fertility Associates is happy to announce the recent addition of Dr. Laura T. Lawrence to their team.

“We are very happy to welcome Dr. Lawrence to our practice,” Founding Partner Dr. Chantilis said. “Her first-rate education, along with her research background and personal experience, make Dr. Lawrence a valuable asset to both our staff and our patients.”

Dr. Lawrence’s distinguished education began at Rice University, where she received her bachelor’s degree in biochemistry. She went on to receive her medical degree from Baylor College of Medicine. Dr. Lawrence completed her Ob/Gyn residency, as well as her Fellowship training in Reproductive Endocrinology, at Washington University in St. Louis, Missouri.

During her residency, Dr. Lawrence had a special interest in teaching, and she received the Resident of the Year teaching award. Says Dr. Lawrence: “My love of teaching benefits my patients because I always place special emphasis on educating women about every aspect of their care.”

Dr. Lawrence has a personal interest in PCOS (polycystic ovarian syndrome) because she was diagnosed with the syndrome in her teens. This experience led her to pursue nationally recognized research into PCOS. Her research investigating glucose intolerance and its corresponding effect on reproduction was supported by several prestigious grants and selected for presentation at multiple national meetings. She was also honored with a Society of Gynecologic Investigation President’s Presenter award.

“Her experience with and research into PCOS, in addition to her special interest in areas like low egg reserve, repeated miscarriages and male factor infertility, will provide our patients with an empathetic and informed approach that they will appreciate,” adds Dr. Chantilis.

For the past five years, Dr. Lawrence has been in practice in the Fort Worth area, serving as the Medical Director of the Harris Methodist ARTS (IVF) Lab. She has been recognized repeatedly with the distinction of Top Doctors from Fort Worth magazine. Dr. Lawrence is looking forward to continuing her tradition of top-notch patient care as part of the DFW Fertility Associates team.

“I hope to use my personal experience and medical expertise to continue to help couples who are struggling with infertility to create their families. I understand their issues and empathize with their obstacles, and it’s an honor to help them.”

About Dallas-Fort Worth Fertility Associates
Dallas-Fort Worth Fertility Associates is a private practice physicians' office specializing in reproductive endocrinology and infertility treatment. Dr. Samuel J. Chantilis, Dr. Karen L. Lee, Dr. Mika R. Thomas, Ravi P Gada and Dr. Laura T. Lawrence, our fertility specialists, are all fellowship-trained in reproductive endocrinology and infertility. Our clinic was opened in an effort to bring the latest IVF treatments and procedures to the Dallas-Fort Worth community. For more information, please visit http://www.dallasfertility.com .

Read the full story at http://www.prweb.com/releases/2014/DFA-Laura/prweb12068427.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
2. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
3. GenturaDx Announces Formation of Scientific Advisory Board
4. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
5. DiaTech Life Sciences Announces Medical Advisory Board
6. BioStorage Technologies Appoints New Member to Board of Directors
7. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
8. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
9. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
10. Coalition to Save Pure Files Proxy Documents With SEC, Urges Pures Board to Set an Annual Meeting Date
11. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/28/2020)... ... January 28, 2020 , ... Today, ... Kits . The new Salivary Total Human IgG Assay Kit exemplifies ... G in saliva, researchers can extend the accuracy and ease of use of ...
(Date:1/24/2020)... ... January 24, 2020 , ... The plastic and reconstructive ... Center in New Jersey epitomize the notion that plastic surgery is much more than ... in popular media. , Over the last 20 years NJ Top Docs, Dr. Andrew ...
(Date:1/23/2020)... , ... January 22, 2020 , ... ... developments in the cosmetic surgery industry at two recent North American investor forums ... at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies and Cardea ... The partners have agreed to co-develop and market a portfolio of CRISPR QC ... programs. Over the longer-term, the parties aim to develop a COBO branded QC ...
Breaking Biology Technology:
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , a ... level, today announced that the company will debut a novel new DNA isolation kit ... The new product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use kit ...
(Date:1/23/2020)... ATLANTA (PRWEB) , ... January 23, 2020 , ... ... to manufacture lifesaving mature red blood cells from stem cells. The red ... red blood cells, under strictly controlled conditions, for transfusion therapy and replaces the ...
(Date:1/22/2020)... ... January 21, 2020 , ... ... transport validation strategies, supporting global regulatory applications, and executing global clinical trial ... Business Journal as a fastest growing company, and ISO 9001:2015 certification with ...
Breaking Biology News(10 mins):